Institute for Cell and Molecular Biosciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Nucleic Acids Res. 2018 May 4;46(8):3878-3890. doi: 10.1093/nar/gky127.
HIF1α (hypoxia inducible factor 1α) is the central regulator of the cellular response to low oxygen and its activity is deregulated in multiple human pathologies. Consequently, given the importance of HIF signaling in disease, there is considerable interest in developing strategies to modulate HIF1α activity and down-stream signaling events. In the present study we find that under hypoxic conditions, activation of the PERK branch of the unfolded protein response (UPR) can suppress the levels and activity of HIF1α by preventing efficient HIF1α translation. Activation of PERK inhibits de novo HIF1α protein synthesis by preventing the RNA-binding protein, YB-1, from interacting with the HIF1α mRNA 5'UTR. Our data indicate that activation of the UPR can sensitise tumor cells to hypoxic stress, indicating that chemical activation of the UPR could be a strategy to target hypoxic malignant cancer cells.
HIF1α(缺氧诱导因子 1α)是细胞对低氧反应的核心调节剂,其活性在多种人类病理中失调。因此,鉴于 HIF 信号在疾病中的重要性,人们非常有兴趣开发调节 HIF1α活性和下游信号事件的策略。在本研究中,我们发现,在低氧条件下,未折叠蛋白反应(UPR)的 PERK 分支的激活可以通过阻止有效的 HIF1α 翻译来抑制 HIF1α 的水平和活性。PERK 的激活通过阻止 RNA 结合蛋白 YB-1 与 HIF1α mRNA 5'UTR 相互作用来抑制新的 HIF1α 蛋白合成。我们的数据表明,UPR 的激活可以使肿瘤细胞对低氧应激敏感,表明化学激活 UPR 可能是靶向缺氧恶性癌细胞的一种策略。